130 related articles for article (PubMed ID: 32745735)
1. Identification of novel scaffold using ligand and structure based approach targeting shikimate kinase.
Rahul Reddy MB; Krishnasamy SK; Kathiravan MK
Bioorg Chem; 2020 Sep; 102():104083. PubMed ID: 32745735
[TBL] [Abstract][Full Text] [Related]
2. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
[TBL] [Abstract][Full Text] [Related]
3. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
[TBL] [Abstract][Full Text] [Related]
4. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI
Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
[TBL] [Abstract][Full Text] [Related]
5. Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations.
Vianna CP; de Azevedo WF
J Mol Model; 2012 Feb; 18(2):755-64. PubMed ID: 21594693
[TBL] [Abstract][Full Text] [Related]
6. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
[TBL] [Abstract][Full Text] [Related]
7. An overview of mechanism and chemical inhibitors of shikimate kinase.
Chagaleti BK; Reddy MBR; Saravanan V; B S; D P; Senthil Kumar P; Kathiravan MK
J Biomol Struct Dyn; 2023; 41(23):14582-14598. PubMed ID: 36974959
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Shikimate Kinase from Methicillin-Resistant
Rios-Soto L; Hernández-Campos A; Tovar-Escobar D; Castillo R; Sierra-Campos E; Valdez-Solana M; Téllez-Valencia A; Avitia-Domínguez C
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791117
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Motion of Shikimate Kinase: Development of Competitive Inhibitors that Stabilize an Inactive Open Conformation of the Enzyme.
Prado V; Lence E; Maneiro M; Vázquez-Ucha JC; Beceiro A; Thompson P; Hawkins AR; González-Bello C
J Med Chem; 2016 Jun; 59(11):5471-87. PubMed ID: 27191386
[TBL] [Abstract][Full Text] [Related]
10. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
Segura-Cabrera A; Rodríguez-Pérez MA
Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
[TBL] [Abstract][Full Text] [Related]
11. Structure-based Discovery of Narirutin as a Shikimate kinase Inhibitor with Anti-tubercular Potency.
Sahu PK; Mohapatra PK; Rajani DP; Raval MK
Curr Comput Aided Drug Des; 2020; 16(5):523-529. PubMed ID: 31654517
[TBL] [Abstract][Full Text] [Related]
12. Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development.
Saidemberg DM; Passarelli AW; Rodrigues AV; Basso LA; Santos DS; Palma MS
Curr Med Chem; 2011; 18(9):1299-310. PubMed ID: 21366533
[TBL] [Abstract][Full Text] [Related]
13. Shikimate kinase, a protein target for drug design.
Coracini JD; de Azevedo WF
Curr Med Chem; 2014; 21(5):592-604. PubMed ID: 24164195
[TBL] [Abstract][Full Text] [Related]
14. Development of an ultrafiltration-liquid chromatography/mass spectrometry (UF-LC/MS) based ligand-binding assay and an LC/MS based functional assay for Mycobacterium tuberculosis shikimate kinase.
Mulabagal V; Calderón AI
Anal Chem; 2010 May; 82(9):3616-21. PubMed ID: 20394394
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C-δ inhibitor, Rottlerin inhibits growth and survival of mycobacteria exclusively through Shikimate kinase.
Pandey S; Chatterjee A; Jaiswal S; Kumar S; Ramachandran R; Srivastava KK
Biochem Biophys Res Commun; 2016 Sep; 478(2):721-6. PubMed ID: 27498028
[TBL] [Abstract][Full Text] [Related]
16. Shikimate Kinase Inhibitors: An Update on Promising Strategy against
Rajput VS; Runthala A; Khan IA
Curr Drug Targets; 2023; 24(5):388-405. PubMed ID: 36752299
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover.
Blanco B; Prado V; Lence E; Otero JM; Garcia-Doval C; van Raaij MJ; Llamas-Saiz AL; Lamb H; Hawkins AR; González-Bello C
J Am Chem Soc; 2013 Aug; 135(33):12366-76. PubMed ID: 23889343
[TBL] [Abstract][Full Text] [Related]
18. Finding the First Potential Inhibitors of Shikimate Kinase from Methicillin Resistant
Rios-Soto L; Téllez-Valencia A; Sierra-Campos E; Valdez-Solana M; Cisneros-Martínez J; Gómez Palacio-Gastélum M; Castillo-Villanueva A; Avitia-Domínguez C
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771148
[TBL] [Abstract][Full Text] [Related]
19. Isolation of alpha-linolenic acid from Sutherlandia frutescens and its inhibition of Mycobacterium tuberculosis' shikimate kinase enzyme.
Masoko P; Mabusa IH; Howard RL
BMC Complement Altern Med; 2016 Sep; 16():366. PubMed ID: 27639973
[TBL] [Abstract][Full Text] [Related]
20. Molecular model of shikimate kinase from Mycobacterium tuberculosis.
Filgueira de Azevedo W; Canduri F; Simões de Oliveira J; Basso LA; Palma MS; Pereira JH; Santos DS
Biochem Biophys Res Commun; 2002 Jul; 295(1):142-8. PubMed ID: 12083781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
